All News

Explore the latest advancements in pharmacy, including innovative therapies, cost-saving models, and significant reforms shaping the industry in 2025.

A recent study reveals COVID-19 vaccination significantly reduces severe maternal disease and preterm birth risks during pregnancy.

Discover critical insights on respiratory health, COVID-19 impacts, and vaccination strategies from recent studies and regional policy changes.

OTC access expands, enhancing reproductive health and migraine relief while raising safety concerns about online pharmacies and medications like Benadryl.

The top pneumococcal stories of 2025 explored the evolving landscape of pneumococcal vaccination.

The landmark oral formulation of the popular weight loss drug is set to launch in early 2026.

Kenric B. Ware, PharmD, MBA, AAHIVP, addresses the pharmacist’s role in addressing HIV stigma and providing public health services for patients with the virus.

The top women's health stories in 2025 included groundbreaking advancements in women's health against an alarming mortality trend.

Personalized insulin management and small lifestyle changes empower diabetes patients to improve their health and confidence in self-care.

With little evidence on vaccine coverage for people living with HIV, researchers explored pneumococcal vaccine rates between 2014 and 2023.

Pharmacists enhance diabetes care by educating patients on insulin management, ensuring safe practices, and tailoring regimens for better glycemic control.

This December 2025 order is an extension of HHS’ recommendation to reconsider marijuana as a Schedule III medication in 2023.

Investigators analyze bureaucratic hurdles in multicountry COVID-19 trials, revealing delays that hinder timely evidence for treatment guidelines.

Among patients previously reporting COVID-19, researchers conduct a case-control study of REM-predominant obstructive sleep apnea.

A pharmacist's guidance is essential when selecting effective OTC cold and influenza medications that provide relief from symptoms such as cough, congestion, and fever.

Ron Lanton III, Esq, discusses previous MFN drug pricing policies and why the free US drug market often yields higher patient costs.

The FDA expands Addyi's approval, offering hope for women under 65 with low sexual desire, marking a significant advancement in women's sexual health.

Amid a lack of research on their specific perspectives, women with epilepsy share their experiences with pregnancy and reproductive health.

FDA approves etripamil nasal spray, offering a rapid, self-administered solution for adults with paroxysmal supraventricular tachycardia (PSVT).

Pharmacists show compassion and support for their communities and patients, highlighting impactful vaccination efforts and dedication to patient care.

Antibiotics are a prominent medication class reserved for helping patients fight bacterial infections.

Delgocitinib is a topical treatment for chronic hand eczema, enhancing options for patients with severe symptoms.

Independent pharmacies tap into Medicare Advantage OTC benefits to boost revenue and enhance patient care in a changing health care landscape.

Oral semaglutide (Rybelsus) reduces the risk of major adverse cardiovascular events in adults with high-risk type 2 diabetes, based on data from the SOUL trial.

The ASHP Midyear Meeting 2025 showcases pharmacy's evolution, emphasizing teamwork, specialized roles, and innovative strategies to enhance patient care and outcomes.

For pharmacies, TrumpRx could redefine how prescription drugs are distributed and reimbursed.

The role of community pharmacists is expanding to combat antibiotic resistance and enhance antimicrobial stewardship.

In an exploration of key stakeholders’ perspectives, researchers assess a lifestyle intervention for cardiometabolic health among women during or after pregnancy.